会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明公开
    • CHLAMYDIA ANTIGENS
    • CHLAMYDIA抗原
    • EP2167530A2
    • 2010-03-31
    • EP08760988.9
    • 2008-06-13
    • Intercell AG
    • MEINKE, AndreasNAGY, EszterNOIGES, BirgitASKLIN, JohannaVON GABAIN, Alexander
    • C07K14/295
    • C07K14/295A61K39/118G01N33/56927G01N2469/20
    • The present invention relates to isolated nucleic acid molecules which encode an antigen from a Chlamydia species, a vector which comprises such nucleic acid molecule, and a host cell comprising such vector. Furthermore, the invention provides antigens from a Chlamydia species, as well as fragments and variants thereof, a process for producing such antigens, and a process for producing a cell, which expresses such antigen. More specifically such antigens are produced by or associated with bacterial infections caused by Chlamydia pneumoniae. Moreover, the present invention provides antibodies binding to such antigen, a hybridoma cell producing such antibodies, methods for producing such antibodies, a pharmaceutical composition comprising such nucleic acid molecule, antigen, vector or antibody, the use of such nucleic acid molecule, antigen, vector or antibody for the preparation of a pharmaceutical composition, methods for identifying an antagonist capable of binding such antigen or of reducing or inhibiting the interaction activity of such antigen, methods for diagnosing an infection with Chlamydia and methods for the treatment or prevention of an infection with Chlamydia.
    • 本发明涉及编码来自衣原体属物种的抗原的分离的核酸分子,包含此类核酸分子的载体和包含此类载体的宿主细胞。 此外,本发明提供了来自衣原体属的抗原及其片段和变体,生产这种抗原的方法,以及生产表达此类抗原的细胞的方法。 更具体地说,这样的抗原由肺炎衣原体引起的细菌感染产生或与之相关。 此外,本发明提供了与这样的抗原结合的抗体,产生这种抗体的杂交瘤细胞,产生这种抗体的方法,包含这种核酸分子,抗原,载体或抗体的药物组合物,这种核酸分子,抗原, 载体或抗体用于制备药物组合物的方法,用于鉴定能够结合此类抗原的拮抗剂或减少或抑制此类抗原的相互作用活性的方法,用于诊断衣原体感染的方法以及用于治疗或预防感染的方法 与披衣菌。
    • 38. 发明公开
    • BORRELIA ANTIGENS
    • 疏螺旋体抗原
    • EP2059526A2
    • 2009-05-20
    • EP07815120.6
    • 2007-09-14
    • Intercell AG
    • LUNDBERG, UrbanMEINKE, AndreasNAGY, EszterVON GABAIN, AlexanderNOIGES, BirgitGELBMANN, DieterPOLJAK, AlbinaTRISKA, Christine
    • C07K14/20
    • C07K7/08A61K39/00A61K2039/53C07K7/06C07K14/20Y02A50/401
    • The present invention relates to isolated nucleic acid molecules which encode a protein, isolated nucleic acid molecules which encode a hyperimmune serum reactive antigen, a vector which comprises such nucleic acid molecule, a host cell comprising such vector, a hyperimmune reactive antigen from Borrelia species, proteins which are preferably hyperimmune serum reactive antigens, hyperimmune serum reactive antigens, antigens, a process for producing such proteins, hyperimmune serum reactive antigens or antigens, a process for producing a cell which expresses such protein, hyperimmune serum reactive antigen or antigen, an antibody binding to such protein, hyperimmune serum reactive antigen or antigen, a hybridoma cell producing such antibody, methods for producing such antibody, a pharmaceutical composition comprising such nucleic acid molecule, protein, hyperimmune serum reactive antigen, antigen or antibody, the use of such nucleic acid molecule, protein, hyperimmune serum reactive antigen, antigen or antibody for the manufacture of a medicament, methods for identifying an antagonist capable of reducing or inhibiting the interaction activity of such protein, hyperimmune serum reactive antigen or antigen, methods for diagnosing an infection and methods for the treatment of an infection. More specifically such proteins, hyperimmune serum reactive antigens or antigens are produced by or associated with bacterial pathogens causing Lyme disease or bacterial infections caused by Borrelia burgdorferi s.1.